YH012
YH012 is a bispecific ADC developed using our RenLite platform, which are intended for the treatment of solid tumor. YH012 is currently at discovery stage.
+86-010-56967680
Copyright © 2021 Biocytogen. All Rights Reserved
Powered by Fractal-technology